The medullary collecting duct is the first nephron segment exposed to E. coli pyelonephritis during an ascending UTI, and so this result provides proof-of-concept for attenuation of pyelonephritis via pharmacologic interventions that target basolateral TLR4 signaling. The gene discussed is TLR4; the disease is bacterial urinary tract infection.